152 related articles for article (PubMed ID: 21282485)
1. Association of socioeconomic status with Breslow thickness and disease-free and overall survival in stage I-II primary cutaneous melanoma.
Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Lucisano G; Labianca R; Marchesi L; Merelli B; Robone S; Poletti P; Milesi L; Tondini C
Mayo Clin Proc; 2011 Feb; 86(2):113-9. PubMed ID: 21282485
[TBL] [Abstract][Full Text] [Related]
2. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of socioeconomic status among patients with malignant melanoma of the skin: a population-based study.
Abdel-Rahman O
J Dermatolog Treat; 2020 Sep; 31(6):571-575. PubMed ID: 31418320
[No Abstract] [Full Text] [Related]
4. Prognostic Significance of Periadnexal Extension in Cutaneous Melanoma and its Implications for Pathologic Reporting and Staging.
Dodds TJ; Lo S; Jackett L; Nieweg O; Thompson JF; Scolyer RA
Am J Surg Pathol; 2018 Mar; 42(3):359-366. PubMed ID: 29240580
[TBL] [Abstract][Full Text] [Related]
5. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thickness.
Ribero S; Galli F; Osella-Abate S; Bertero L; Cattaneo L; Merelli B; Tondini C; Ghilardi L; De Giorgi V; Occelli M; Quaglino P; Cassoni P; Palmieri G; Massi D; Mandala M;
J Am Acad Dermatol; 2019 Jan; 80(1):99-105.e5. PubMed ID: 30447951
[TBL] [Abstract][Full Text] [Related]
7. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
[TBL] [Abstract][Full Text] [Related]
8. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment.
Zell JA; Cinar P; Mobasher M; Ziogas A; Meyskens FL; Anton-Culver H
J Clin Oncol; 2008 Jan; 26(1):66-75. PubMed ID: 18165642
[TBL] [Abstract][Full Text] [Related]
9. Socioeconomic status and survival in older patients with melanoma.
Reyes-Ortiz CA; Goodwin JS; Freeman JL; Kuo YF
J Am Geriatr Soc; 2006 Nov; 54(11):1758-64. PubMed ID: 17087705
[TBL] [Abstract][Full Text] [Related]
10. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
McKenna DB; Lee RJ; Prescott RJ; Doherty VR
Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
[TBL] [Abstract][Full Text] [Related]
11. Impact of socioeconomic status and district of residence on cutaneous malignant melanoma prognosis: a survival study on incident cases between 1991 and 2011 in the province of Ferrara, northern Italy.
Borghi A; Corazza M; Virgili A; Lambertini AG; Caranci N; Pacelli B; Carcoforo P; Ferretti S
Melanoma Res; 2017 Dec; 27(6):619-624. PubMed ID: 28723726
[TBL] [Abstract][Full Text] [Related]
12. Tumor-infiltrating lymphocytes predict cutaneous melanoma survival.
Fortes C; Mastroeni S; Mannooranparampil TJ; Passarelli F; Zappalà A; Annessi G; Marino C; Caggiati A; Russo N; Michelozzi P
Melanoma Res; 2015 Aug; 25(4):306-11. PubMed ID: 25933208
[TBL] [Abstract][Full Text] [Related]
13. Effects of time interval between primary melanoma excision and sentinel node biopsy on positivity rate and survival.
Oude Ophuis CM; van Akkooi AC; Rutkowski P; Voit CA; Stepniak J; Erler NS; Eggermont AM; Wouters MW; Grünhagen DJ; Verhoef CK
Eur J Cancer; 2016 Nov; 67():164-173. PubMed ID: 27669503
[TBL] [Abstract][Full Text] [Related]
14. Clinico-pathological features of patients with melanoma and positive sentinel lymph node biopsy: a single institution experience.
Homolak D; Šitum M; Čupić H
Acta Dermatovenerol Croat; 2015; 23(2):122-9. PubMed ID: 26228823
[TBL] [Abstract][Full Text] [Related]
15. Mitotic rate correlates with sentinel lymph node status and outcome in cutaneous melanoma greater than 1 millimeter in thickness: A multi-institutional study of 1524 cases.
Mandalà M; Galli F; Cattaneo L; Merelli B; Rulli E; Ribero S; Quaglino P; De Giorgi V; Pigozzo J; Sileni VC; Chirco A; Ferrucci PF; Occelli M; Imberti G; Piazzalunga D; Massi D; Tondini C; Queirolo P;
J Am Acad Dermatol; 2017 Feb; 76(2):264-273.e2. PubMed ID: 27847125
[TBL] [Abstract][Full Text] [Related]
16. Sociodemographic factors and incidence of melanoma in the Netherlands, 1994-2005.
van der Aa MA; de Vries E; Hoekstra HJ; Coebergh JW; Siesling S
Eur J Cancer; 2011 May; 47(7):1056-60. PubMed ID: 21251812
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
18. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
[TBL] [Abstract][Full Text] [Related]
19. Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study.
Tejera-Vaquerizo A; Ribero S; Puig S; Boada A; Paradela S; Moreno-Ramírez D; Cañueto J; de Unamuno B; Brinca A; Descalzo-Gallego MA; Osella-Abate S; Cassoni P; Carrera C; Vidal-Sicart S; Bennássar A; Rull R; Alos L; Requena C; Bolumar I; Traves V; Pla Á; Fernández-Orland A; Jaka A; Fernández-Figueres MT; Hilari JM; Giménez-Xavier P; Vieira R; Botella-Estrada R; Román-Curto C; Ferrándiz L; Iglesias-Pena N; Ferrándiz C; Malvehy J; Quaglino P; Nagore E;
Cancer Med; 2019 Aug; 8(9):4235-4244. PubMed ID: 31215168
[TBL] [Abstract][Full Text] [Related]
20. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
Statius Muller MG; van Leeuwen PA; de Lange-De Klerk ES; van Diest PJ; Pijpers R; Ferwerda CC; Vuylsteke RJ; Meijer S
Cancer; 2001 Jun; 91(12):2401-8. PubMed ID: 11413531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]